Category

Archives

Blog of Signaling Pathways

HBO2 may produce great benefits to radiation necrosis populations

1585 views | Oct 11 2011

Radiation tissues injury (radiation necrosis) is a "side effect" of radiation therapy for a tumor and can develop months or years after treatment with radiation. Especially in the irradiated area, destruction of nutrient blood vessels can result in local ulceration, destruction of bone and bleeding. This damage inhibits the ability of the irradiated tissue to repair itself, and a radiation necrosis wound can gradually affect and involve surrounding tissue. Affected patients may become socially isolated and are suffered from depression, or nutritional deficiency. [Read the Full Post]

Enzastaurin, as the inhibitor of PKC, may be a novel PNC medical therapy

4382 views | Sep 29 2011

Pancreatic cancer is the fourth most common cause of cancer death both in the United States. Regarding the pathology, pancreatic cancer mainly includes exocrine pancreas cancers, pancreatic cystic neoplasms and endocrine pancreatic cancers. Pancreatic neuroendocrine cancers (PNC) account for less than 3% of pancreatic tumors and the main treatments are surgery, hormone therapy, chemotherapy and so on at this stage. However, It is still needed to search for effective treatments for PNC, and understand the molecular pathways regulating neuroendocrine tumor cell proliferation. [Read the Full Post]

S6K and PDK1 modulate neuronal size specification

5870 views | Sep 22 2011

Synapse is located in the nervous system and a structure that passes an electrical or chemical signalfrom a neuron to another cell. The presynaptic terminal is a specialized area within the axon of the presynaptic cell that contains neurotransmitters enclosed in small membrane-bound spheres called synaptic vesicles. Active zones is a region that synaptic vesicles are docked at the presynaptic plasma membrane. [Read the Full Post]

Effects of PARP inhibitors in BRCA gene-mutated ovarian cancer

11299 views | Sep 20 2011

Ovarian cancer is a cancerous growth arising from the ovary, and remains the leading cause of death from gynecological cancer, accounting for more than 140,000 deaths per year worldwide. The risk of developing ovarian cancer appears to be affected by several factors, and 10% of ovarian cancer patients have a family history of the disease. Certain genes defects (BRCA1 and BRCA2) are considered to be responsible for a small number of ovarian cancer cases. [Read the Full Post]

FLT3 ligand enhances efficacy of RNA Vaccines in cancer therapy

4109 views | Sep 14 2011

Vaccines work on the principle of promote the immune system to recognize an invader and attack it more quickly, before it can do any harm. Recently, self-replicating RNA vaccines have emerged as an effective and safe approach to induce antitumor immunity. Self-replicating RNA can replicate in a diverse range of cell types, allows the expression of the Ag of interest at high levels, and eventually causes lysis of transfected cells. [Read the Full Post]

Alexander V. Sirotkin “The role of protein kinases in control of ovarian functions”

2681 views | Sep 13 2011

Control of basic physiological processes including reproduction requires multilevel signaling system, which includes hormones, growth factors and related molecules, their receptors and binding proteins, whose alter expression of target genes via protein kinases (PKs) and transcription factors. These signaling substances can control reproductive processes via production, binding and metabolism of regulators of cell cycle, apoptosis, secretory activity, differentiation and oogenesis. [Read the Full Post]

Boosani “Endogenous angiogenesis inhibitors affecting cell survival pathways”

2437 views | Sep 13 2011

Phosphatidylinositol 3-kinases (PI3 kinases) are a group of enzymes categorized into three different classes, among them class I isoforms are well characterized (Stein, 2001). These kinases are the key enzymes that are vital for cell survival with essential role in several cellular functions such as growth, proliferation, differentiation, motility, and intracellular signaling. PI3 Kinases are activated by tyrosine kinases with Akt being the downstream effector molecule (Hennessy et al., 2005). [Read the Full Post]

Novel CDK2 Inhibitors as Anti-Tumor Agents

2427 views | Sep 09 2011

Conventional anti-cancer drugs have mainly focused on targeting DNA synthesis and cell division.n order to avoid these adverse effects, investigators begin to develop a new class of anti-cancer agents, and signal transduction or secondary message inhibitors is one of the successful research findings. [Read the Full Post]

HDACs, play important roles in kidney development

5474 views | Sep 08 2011

Histone deacetylases (HDACs) regulate fundamental biological processes such as cellular proliferation, differentiation, and survival via genomic and non-genomic effects. Some data suggest that HDACs may play a important role in kidney development. [Read the Full Post]

p38 MAPK inhibitor, FR167653, a potent therapy against PTHrP-induced osteoclastogenesis and bone resorption-related diseases

3117 views | Sep 07 2011

Study on mechanism indecates that PTHrP stimulates osteoclastogenesis by increasing receptor activator of NF-kB ligand (RANKL) expression. p38 MAPK is required for osteoclast differentiation. This implies the existence of relationship between p38 MAPK and PTHrP in osteoclastogenesis. [Read the Full Post]

FGFs and the downstream signaling involve in tissue regeneration

4117 views | Sep 06 2011

FGFs have the biological activity of inducing cell proliferation, migration, differentiation, and angiogenesis. As one of the critical components in tissue regeneration, fibroblast growth factors (FGFs) shown the potential effects on the repair and regeneration of tissues. [Read the Full Post]

PI3K/Akt inhibition modulates multidrug resistance

4497 views | Sep 05 2011

Multidrug resistance (MDR), characterized by cancer cell resistance to multiple chemotherapeutic drugs, is a major clinical obstacle in the treatment of hematological malignancies. And many investigators have comfirmed that the PI3K/Akt pathway is associated with chemoresistance in cancer cells. [Read the Full Post]

Li, C., S. Chi, et al. (2011). "Hedgehog signaling in skin cancers." Cell Signal 23(8): 1235-1243.

2970 views | Aug 20 2011

This article introduces the relationship between hedgehog signal transduction and cancer including Skin cancers linked to aberrant hedgehog pathway activity, models of Hh pathway activity in cancer and implications for therapy, and inhibitors and modulators of Hh pathway and their application in skin cancers. [Read the Full Post]

Shaw, A. T. and B. Solomon (2011). "Targeting anaplastic lymphoma kinase in lung cancer." Clin Cancer Res 17(8): 2081-2086.

3706 views | Aug 19 2011

This article reviews the ALK pathway and the Clinical–Translational Advances of different ALK inhibitors. [Read the Full Post]

Kong, X., Y. Shen, et al. (2011). "Emerging roles of DNA-PK besides DNA repair." Cell Signal 23(8): 1273-1280.

4635 views | Aug 19 2011

This article reviews the role of DNA-PK from two aspects. It not only introduces the regulation of DNA-PK activity and the roles of DNA-PK in non-homologous end-joining (NHEJ) repair and homologous recombinant (HR) repair, but also introduces the involvement of DNA-PK in the inflammatory response, in metabolic gene regulation, and in the homeostasis of cell proliferation as well. [Read the Full Post]

Brinkmann, V. (2007). "Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology." Pharmacol Ther 115(1): 84-105.

3213 views | Jul 22 2011

This article reviews S1P receptor subtypes and associated signaling pathways. The relationship between S1P receptors and different diseases is proved in the article. [Read the Full Post]

Huang, H., A. Bhat, et al. (2010). "Targeting the ANGPT-TIE2 pathway in malignancy." Nat Rev Cancer 10(8): 575-585.

3222 views | Jul 20 2011

This article which is published in Nature review cancer introduce the role of Tie2 in signal transduction such as angiogenesis. It also concludes the inhibitors of Tie2 kinase in cancer therapeutics. [Read the Full Post]

Chiarle, R., C. Voena, et al. (2008). "The anaplastic lymphoma kinase in the pathogenesis of cancer." Nat Rev Cancer 8(1): 11-23.

4142 views | Jul 19 2011

This review which was published in Nature Reviews Cancer concludes the pathways which ALK is involved in and targets that ALK is related to. The content also includes ALK as a therapeutic target in cancer. [Read the Full Post]

Rosse, C., M. Linch, et al. (2010). "PKC and the control of localized signal dynamics." Nat Rev Mol Cell Biol 11(2): 103-112.

4458 views | Jul 19 2011

This review which was published in Nature review summary the role of PKC in different pathways and show the importance of PKCs in controlling spatial resolution in signaling processes using the MET and STAT3 example. [Read the Full Post]

Mumenthaler, S. M., P. Y. Ng, et al. (2009). "Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes." Mol Cancer Ther 8(10): 2882-2893.

4497 views | Jul 17 2011

These findings support the idea that inhibiting Pim kinases, in combination with a chemotherapeutic agent, could play an important role in prostate cancer treatment by targeting the clinical problem of chemoresistance. [Read the Full Post]